---
category: news
title: "Israel’s Immunai to use $215 mil. investment to develop, test new drugs"
excerpt: "Israeli-American biotech company Immunai is best known for its development of the world’s largest data atlas of clinically annotated single-cell immune data."
publishedDateTime: 2021-06-19T20:00:00Z
originalUrl: "https://www.jpost.com/health-and-wellness/israels-immunai-to-use-215-mil-investment-to-develop-test-new-drugs-683266"
webUrl: "https://www.jpost.com/health-and-wellness/israels-immunai-to-use-215-mil-investment-to-develop-test-new-drugs-683266"
ampWebUrl: "https://m.jpost.com/health-and-wellness/israels-immunai-to-use-215-mil-investment-to-develop-test-new-drugs-683266/amp"
cdnAmpWebUrl: "https://m-jpost-com.cdn.ampproject.org/c/s/m.jpost.com/health-and-wellness/israels-immunai-to-use-215-mil-investment-to-develop-test-new-drugs-683266/amp"
type: article

provider:
  name: The Jerusalem Post Blogs
  domain: jpost.com

topics:
  - AI

images:
  - url: "https://images.jpost.com/image/upload/f_auto,fl_lossy/t_JM_ArticleMainImageFaceDetect/485949"
    width: 640
    height: 428
    isCached: true

secured: "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;Jt1v0k8pXYXxtJRG9PaU4w=="
---

